Adult T-cell leukemia/lymphoma (ATLL) is a mature T-cell lymphoproliferative disorder
associated with the human T lymphotropic virus (HTLV-1) infection. ATLL predominantly …

Adult T-cell leukemia/lymphoma (ATLL) is an aggressive malignancy of CD4+ T
lymphocytes caused by human T lymphotropic virus type-1 (HTLV-1) infection. HTLV-1 was …

Adult T-cell leukemia/lymphoma (ATL) is a heterogeneous group of peripheral T-cell
malignancies characterized by human T-cell leukemia virus type-1 infection, whose genetic …

Adult T-cell leukemia/lymphoma (ATLL) is the neoplasm caused by human T-cell leukemia
virus type 1 (HTLV-1). We performed oligo-array comparative genomic hybridization (CGH) …

Adult T-cell leukemia lymphoma (ATLL) is a rare T cell neoplasm that is endemic in
Japanese, Caribbean, and Latin American populations. Most North American ATLL patients …

Aggressive adult T-cell leukemia/lymphoma (ATLL) such as acute and lymphoma types are
fatal diseases with poor prognosis. Although these 2 subtypes feature different …

Adult T-cell leukemia/lymphoma (ATL) is a human T-cell leukemia virus type-1–induced
neoplasm with four clinical subtypes: acute, lymphoma, chronic, and smoldering. Although …

Adult T-cell leukemia/lymphoma (ATLL) is a peripheral T-cell neoplasm of highly
pleomorphic lymphoid cells. ATLL is usually widely disseminated, and it is caused by human …

Subclonal genetic heterogeneity and their diverse gene expression impose serious
problems in understanding the behavior of cancers and contemplating therapeutic …

There is an urgent unmet need for developing novel therapies in ATL in order to improve
survival. Recent advances in the molecular and epigenetic landscape of ATL, and the early …